Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

RSPH vs LOGSX overlap: 21% of top holdings shared

Bottom line

How much do RSPH and LOGSX overlap?

21% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 10.8% of RSPH's assets and 23.3% of LOGSX's. They are substantially different portfolios, so owning both adds real diversification.

RSPH holds far more positions (63 vs 28), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

RSPHLOGSX
Weight overlap (top 25)21%
Shared holdings6
Weight in shared holdings10.8%23.3%
Total positions6328
Expense ratio0.4%1.04%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings RSPH and LOGSX have in common

Holding% of RSPH% of LOGSXOverlap
Regeneron Pharmaceuticals, Inc.1.96%4.43%1.96%
Bristol-Myers Squibb Co.1.82%4.02%1.82%
Labcorp Holdings Inc.1.78%2.29%1.78%
Amgen Inc.1.77%4.86%1.77%
Incyte Corp.1.76%3.30%1.76%
Cencora, Inc.1.71%4.46%1.71%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Mettler-Toledo International Inc. — 1.94%
  5. Charles River Laboratories International, Inc. — 1.93%
  6. Veeva Systems Inc. — 1.93%
  7. DaVita Inc. — 1.87%
  8. Moderna, Inc. — 1.85%
  9. Thermo Fisher Scientific Inc. — 1.84%
  10. Abbott Laboratories — 1.83%
  11. Universal Health Services, Inc. — 1.80%
  12. Quest Diagnostics Inc. — 1.77%
  13. Becton, Dickinson and Co. — 1.73%
  14. DexCom, Inc. — 1.73%
  15. AbbVie Inc. — 1.73%

Only in LOGSX

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Lantheus Holdings Inc — 4.68%
  7. Novartis Ag — 4.67%
  8. Mckesson Corp — 4.53%
  9. National Healthcare Corp — 3.87%
  10. Johnson & Johnson — 3.77%
  11. Medpace Holdings Inc — 3.69%
  12. Gilead Sciences Inc — 3.50%
  13. Cigna Group (the) — 3.46%
  14. Vertex Pharmaceuticals Inc — 3.26%
  15. Merck & Company Inc — 3.16%

Asset mix

Asset typeRSPHLOGSX
Stocks99.9%97.2%
Repurchase agreements—6.9%
Cash & short-term funds2.3%1.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryRSPHLOGSX
US98.9%89.7%
IE3.4%8.8%
CH—4.7%
DK—2.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do RSPH and LOGSX overlap?
About 21% by weight. 6 securities appear in both funds' top 25 holdings; they make up 10.8% of RSPH's assets and 23.3% of LOGSX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do RSPH and LOGSX have in common?
The largest shared holdings are Regeneron Pharmaceuticals, Inc., Bristol-Myers Squibb Co., Labcorp Holdings Inc., Amgen Inc., Incyte Corp..
Should I own both RSPH and LOGSX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, RSPH or LOGSX?
RSPH is broader, with 63 positions versus 28 for LOGSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.